Pressure Injury Prevention Post-market Clinical Follow up Study, Biatain Silicone Sacral

A prospective single-arm study investigating the safety of Biatain Silicone Sacral while used as prophylactic prevention amongst hospital admitted patients at risk of developing a pressure injury.

Inclusion Criteria:Hospital-admitted patients at risk of developing a pressure injury with an expected hospital-stay of more than 24 hours from visit 1≥18 years of age and has full legal capacityHas given written consent to participate by signing the Informed Consent signature FormHas a Braden score of 6-18 at screening (performed within the last 24 hours)Intact sacral skin (non-breached skin, without signs of non-blanchable erythema over bony prominence/pre-existing sacral pressure injury over bony prominence)Exclusion Criteria:Suspected or actual spinal injury precluding the patient from being turnedSacral erythema, sacral pressure marks, pre-existing sacral pressure injuryTrauma to sacrumTopical treatment with steroid creme in the sacral area (treatment must have been terminated at least 14 days prior to enrollment)Pregnancy or breastfeeding